RollingStone Co., Ltd. (KOSDAQ:214610)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,240.00
-130.00 (-3.86%)
At close: Feb 13, 2026
Market Cap27.14B -55.4%
Revenue (ttm)891.68M -89.3%
Net Income-21.07B
EPS-345.66
Shares Out8.38M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume61,743
Average Volume26,791
Open3,360.00
Previous Close3,370.00
Day's Range3,240.00 - 3,400.00
52-Week Range3,155.00 - 9,750.00
Beta0.26
RSI37.79
Earnings DateMar 20, 2026

About RollingStone

RollingStone Co., Ltd. provides point-of-care-testing diagnostic systems based on Lab-on-a-Chip technology. The company offers molecular diagnostics devices comprising Veri-Q PREP M16 (G2-16TU) system, a device that include membrane to extract nucleic acid using tube; VERI-Q PCR 316, a device to get the result in a short time using plastic chip; VERI-Q PCR 204 (G2-4), a device to deliver the real-time PCR system; PCR and sample prep kits; Veri-Q PCR 316 PB products; and LabChip, sample tube, and pre-filtering column products. It also provides b... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2009
Employees 48
Stock Exchange KOSDAQ
Ticker Symbol 214610
Full Company Profile

Financial Performance

In 2024, RollingStone's revenue was 4.64 billion, a decrease of -13.55% compared to the previous year's 5.37 billion. Losses were -30.85 billion, 19.7% more than in 2023.

Financial Statements